Skip to main content

Cite the Grant

Funding.png
NIH Funding Acknowledgment on ACTRI Publications/Projects  

NIH Funding Acknowledgment on ACTRI Publications/Projects

All publications/projects resulting from the utilization of any ACTRI resources are required to:  

  • Credit the CTSA grant  
  • Comply with NIH Public Access Policy and be assigned a PMCID

All peer-reviewed publications resulting from NIH-funded research must be submitted to PubMed Central upon acceptance and made publicly available at publication, with proper acknowledgment of NIH funding. Compliance is required as a condition of NIH funding and ensures public access to federally funded research.

Frequently Asked Questions

Who needs to cite the CTSA grant?

Principal Investigators (PIs) and researchers must cite the CTSA grant (UM1 TR005449) in any resulting publications, posters, or presentations in which they are an author or co-author if their work was supported by ACTRI in any of the following ways:

Required citation applies for any of the following:

  • You are a Pilot Grant awardee, K12 scholar, or ACTRI voucher awardee
  • Your research benefited from ACTRI-funded faculty or staff support
  • Your project utilized ACTRI services, resources, or infrastructure, including but not limited to support ranging from biostatistics and informatics to regulatory guidance, recruitment and retention, study coordination and design, and community engagement.
  • You used ACTRI-supported tools, platforms, or resources, including but not limited to REDCap, Velos eResearch, ENACT Network, UCSD Health Secure Research Enclave, Virtual Secure Workstation (VSW), eFlorence, and/or ACTRI toolkits, training, and educational programs.

How do I cite the CTSA grant?

Please use the following language to acknowledge the CTSA grant in publications: 

Required Funding Acknowledgement

“This publication was supported in part by the Altman Clinical and Translational Research Institute at the University of California, San Diego, funded by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UM1TR005449. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

This manuscript is subject to the NIH Public Access Policy, and the final peer-reviewed manuscript will be made publicly available in PubMed Central upon the Official Date of Publication.”

K12 scholars are also required to cite the K12 grant, using the following language:  

“This publication was supported in part by the Altman Clinical and Translational Research Institute at the University of California, San Diego, funded by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UM1TR005449 and K12TR005441. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

This manuscript is subject to the NIH Public Access Policy, and the final peer-reviewed manuscript will be made publicly available in PubMed Central upon the Official Date of Publication.”

 

CTSA Support Period

 CTSA Hub Award

 CTSA Training Awards 

After August 1, 2025 - Present

UM1TR005449 

K12TR005441

2015 – 2025

UL1TR001442

KL2TR001444

2010 – 2015

UL1RR031980

KL2RR031978, TL1RR031979, 5TL1TR001443

 

Publication Costs

ACTRI is unable to cover open-access fees or other publication costs associated with citing the CTSA award. Authors and collaborating institutions must determine responsibility for these costs before selecting a journal and submitting a manuscript.

UC San Diego may cover some publication fees through its existing publisher agreements. Eligibility depends on the terms of the specific agreement and requires that an eligible UC San Diego author serve as the corresponding author. The presence of a UC San Diego coauthor or acknowledgment of the CTSA award does not, by itself, qualify an article for coverage.

Before submission, authors should review the UC San Diego Library’s NIH Public Access and publishing guidance and confirm whether the selected journal and article qualify for coverage. If the article is not covered, the authors must identify another funding source or use a no-cost compliance pathway, such as depositing the author-accepted manuscript through the NIH Manuscript Submission system (NIHMS).

Publication costs do not remove the requirement to comply with the NIH Public Access Policy.

NIH Public Access Compliance

Public access is required for publications arising from NIH-funded research or activities, including those supported in whole or in part by the CTSA award. Publications subject to the NIH Public Access Policy must be submitted to PubMed Central upon acceptance. The final peer-reviewed manuscript must be publicly available without an embargo by the official date of publication.

Authors who acknowledge funding from the CTSA award are responsible for helping ensure compliance with the NIH Public Access Policy. Noncompliance may delay continued funding of the CTSA award and could affect future NIH funding for the institution and the publication’s authors.

For additional information, see the NIH Public Access Policy Overview.

How to Submit for Public Access Compliance

Compliance does not require payment of a journal’s open-access fee. Authors may use the NIH Manuscript Submission System (NIHMS) to deposit the author-accepted manuscript in PubMed Central at no cost.

Before submitting to a journal, authors must confirm that the publishing agreement permits compliance with the NIH Public Access Policy. Detailed instructions are available in the NIHMS submission guide.

Submission instructions:

  1. Sign in to NIHMS.
  2. Select Add Manuscript.
  3. Enter the publication and funding information.
  4. Upload the complete author-accepted manuscript and all associated files.
  5. Designate yourself as the reviewer.
  6. Select Immediate Release or a release delay of 0 months.
  7. Respond promptly to NIHMS email notifications and complete all required approval steps. A PMCID will be assigned after final approval and processing.

Journal Deposit and Embargo Requirements  

For manuscripts subject to the current NIH Public Access Policy, an embargo is not permitted. The manuscript must be publicly available in PubMed Central by the official date of publication. A journal’s standard embargo period does not override this NIH requirement.

Some journals, often referred to as Method A journals, have agreements to deposit articles directly in PubMed Central. However, inclusion in the PMC Journal List does not automatically confirm compliance. Before submission, authors must verify that the journal has:

  • An active PMC deposit agreement; and
  • A release delay of zero months, indicating immediate public availability.

If a journal applies an embargo, authors must use one of the following compliance pathways:

  • Ask the journal to deposit the final article in PubMed Central without an embargo; or
  • Submit the accepted manuscript through NIHMS and select 0 months as the release delay.
  • If the journal submits through NIHMS with an embargo, the designated reviewer must change the release delay to 0 months.

Authors should confirm the compliant deposit pathway before signing a publication agreement or paying a publication fee.

See NIH Public Access and PMC for additional guidance.

Questions?

For any questions, please reach out to actri-publications@health.ucsd.edu.  

ACTRI Publications

Advancing scientific knowledge through publications is essential for understanding diseases and improving health. UCSD researchers supported by ACTRI share their findings in various academic journals, and you can explore recent publications below or view the full collection on PubMed.

Click to access our Publications page